dc.identifier.citation |
1. International conference on harmonization (ICH) validation of analytical procedures; Definitions and terminology, 60, Federal Register. 1999;11260-11267. 2. Moffat AC, Osselton MD, Winddop B. Clarkes analysis of drug and poisons, 3rd ed., Pharm. Press, London, UK. 2004;1312. 3. Yuan-Yi C, Lok-Hi C, Chun-Chien H. Gender and pain upon movement are associated with requirements for postoperative patient controlled I.V. analgesia. Canad. J. Anesth. 2002;49:249-255. 4. El-Tohamy M, El-Maamly M, Shalaby A, Aboul- Eneiny H. Development of nalbuphine- Selective membrane electrode and its applications in pharmaceutical analysis. Anal. Lett. 2007;40(7-9):1569-1578. 5. Yoo Y, Chung H, Kim I, Jin W, Kim M. Determination of nalbuphine in drug abusers urine. J.Anal. Toxicol. 1995;19(2):120-123. 6. Xu – Y, Fang H, Xu Y, Duan H. Studies on the analysis of anileridine, levorphanol, nalbuphine and ethamivan in urine. Yaoxue Xuebao. 1991;26(8):606-610. 7. Fang H, Duan H, Zhou T Chen Y. Studies on the analysis of some narcotic analgesics and CNS stimulants. Zhongguoyaoxue. Zazhi. 1989;24(10):759-768. 8. Kintz P, Tracqui A, Mangin P. Determination of nalbuphine using high-performance liquid chromatography coupled to photodiode array detection and gas chromatography coupled to mass spectrometry. J Chromatogr. Biomed. Appl. 1992;579:172-176. 9. Groenendoal D, Roosemalen M, Danhof M, Lange E. High-performance liquid chromatography of nalbuphine, butorphenol and morphine in blood and brain microdialysate samples. J. Chromatogr. B. 2005;822:230-237. 10. Pav L, Hisong C, Hu O, Shung H. High – Performance liquid chromatographic method for the simultaneous determination of nalbuphine and its prodrug sebacoyl dinalbuphine ester in dog plasma and application to pharmacokinetic studies in dogs. J. Chromatogr. B. 2006;746:241-247.11. Cazanove F, Kinowski J, Audran M, Rochette A, Bressolle F. Determination of nalbuphine in human plasma by high-performance liquid chromatography with electrochemical detection. J. chromatogr. B. 1997;690:203-210. 12. Borg P, Sitaram BR, Taylor DA. Ion- pair extraction and liquid-chromatographic analysis of morphine in rat brain and plasma. J. Chromatogr. Biomed. Appl. 1993; 132(2):165-172. 13. Ho S, Wang J, Hu O, Chiang P, Lee S. Determination of nalbuphine by highperformance liquid chromatography with ultraviolet detection. J. Chromatog. B. 1996; 678:289-296. 14. Nicolle E, Michaut S, Serre – Debeauvais F, Bessard G. Rapid and sensitive highperformance liquid chromatographic assay for nalbuphine in plasma. J. Chromatogr. B. 1995;663:111-117. 15. Sokol A, Kappinska J, Talecka R, Starczewska B. Quantification of ranitidine hydrochloride in the presence of its decomposition product by sepectrophotometric methods. Application for kinetic study. Acta. Poloniae Pharm. Drug Res. 2011;68(2):169-177. 16. Lopez-Martinez L, Lopez-Alba P, Martin V. Bivariate calibration as an alternative for zero – crossing technique in the resolution of binary mixtures by derivative spectrophotometry. Anal. Lett. 2001; 34(14):2563-2583. 17. Ska J, Wiszowata A, Skocyzales M. Simultaneous determination of levomeperazine hydrochloride and its sulfoxide by UV- derivative spectrophotometry and bivariate calibration method. Anal. Lett. 2006; 39(6):1129-1141. 18. Rashed NS. Stability indicating methods for the determination of ethopabate. Bull. Fac. Pharm. Cairo. Univ. 2008;46(3):191-200. 19. Salamaa FM, Nassar MW, Sharaf El-Din MM, Attia KA, Kaddah MY. Determination of fenofibrate and its degradation product using simultaneous UV–derivative spectrometric method and HPLC. American J. Anal. Chem. 2011;2(3):332-343. |
en_US |